Elevance Health Publishes Q3 2026 Earnings Call Transcript

Bitget2026/10/21 23:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Elevance Health held its third-quarter 2026 earnings call October 21, attended by CEO Gail Boudreaux, CFO Mark Kaye and other executives.
Management raised full-year adjusted diluted earnings per share guidance to at least $29, reflecting operating outperformance and favorable nonoperating items.
The earnings baseline increased $0.75 to at least $26.75, supporting projected adjusted diluted earnings per share growth of at least 12% in 2027.
Quarterly adjusted diluted earnings per share reached $6.99, exceeding expectations; the consolidated benefit expense ratio improved 70 basis points to 90.6%.
Medicaid margins should improve in 2027 as reimbursement rates better reflect costs; underlying cost trends remained elevated but stable.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Elevance Health Publishes Q3 2026 Earnings Call Transcript

You may also like

Crypto prices